Christopher Bowden's Net Worth
$6.02 Million
Who is Christopher Bowden?
Christopher Bowden has an estimated net worth of $6.02 Million. This is based on reported shares across multiple companies, which include Alaunos Therapeutics, Inc., AGIOS PHARMACEUTICALS INC, and MIRAGEN THERAPEUTICS, INC..
SEC CIK
Christopher Bowden's CIK is 0001608601
Past Insider Trading and Trends
2021 was Christopher Bowden's most active year for acquiring shares with 17 total transactions. Christopher Bowden's most active month to acquire stocks was the month of January. 2018 was Christopher Bowden's most active year for disposing of shares, totalling 27 transactions. Christopher Bowden's most active month to dispose stocks was the month of January. 2021 saw Christopher Bowden paying a total of $4,699,811.08 for 208,052 shares, this is the most they've acquired in one year. In 2021 Christopher Bowden cashed out on 228,241 shares for a total of $6,375,381.94, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Alaunos Therapeutics, Inc. (TCRT) Snapshot price: $2.83
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +959.92% | 40K |
—
|
—
| 44.17K |
Jun 22
| |||
Form 4
|
∞
| 4.17K |
—
|
—
| 4.17K |
Mar 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 25
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
AGIOS PHARMACEUTICALS, INC. (AGIO) Snapshot price: $43.28
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
$55.05 | -$490,860.39 | 15.49K |
Scheduled
|
Jun 18
| ||
Form 4
|
—
|
0
|
$49.89 | -$50,690.02 | 15.49K |
Scheduled
|
Jun 17
| ||
Form 4
|
—
|
0
|
$49.93 | -$569,194.64 | 15.49K |
Scheduled
|
Jun 9 - Jun 10
| ||
Form 4
|
—
|
0
|
$49.91 | -$222,077.24 | 15.49K |
Scheduled
|
Jun 7 - Jun 8
| ||
Form 4
|
—
|
0
|
$45.39 | -$342,748.56 | 15.49K |
Scheduled
|
Apr 19 - Apr 20
| ||
Form 4
| +17.98% | 2.35K |
—
|
—
| 15.41K |
Feb 22 - Feb 24
| |||
Form 4
| +55.85% | 4.68K |
—
|
—
| 13.06K |
Feb 14 - Feb 16
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 10
| |||
Form 4
|
—
|
0
|
$42.58 | -$53,221.88 | 8.31K |
Scheduled
|
May 20
| ||
Form 4
| +54.76% | 2.91K |
$40.64 | -$96,235.52 | 8.23K |
Apr 13 - Apr 14
| |||
Form 4
| +48.51% | 1.74K |
$48.66 | -$77,661.36 | 5.32K |
Feb 22 - Feb 24
| |||
Form 4
| +117.03% | 1.93K |
$52.01 | -$42,596.19 | 3.58K |
Feb 14 - Feb 18
| |||
Form 4
|
—
|
0
|
$42.66 | -$106,475.86 | 1.65K |
Scheduled
|
Feb 13
| ||
Form 4
|
—
|
0
|
$42.59 | -$9,228.87 | 1.65K |
Scheduled
|
Feb 11
| ||
Form 4
| -77.44% | -5.67K |
$42.62 | -$939,898.13 | 1.65K |
Scheduled
|
Feb 4 - Feb 5
| ||
Form 4
|
—
|
0
|
$50.86 | -$314,146.72 | 7.24K |
Scheduled
|
Apr 1
| ||
Form 4
|
—
|
0
|
$49.66 | -$290,015.00 | 7.24K |
Scheduled
|
Mar 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 22
| |||
Form 4
| +36.71% | 1.93K |
$58.03 | -$47,468.54 | 7.2K |
Feb 16 - Feb 19
| |||
Form 4
| +465.91% | 4.3K |
$52.82 | -$103,527.20 | 5.23K |
Jan 20 - Jan 22
| |||
Form 4
|
—
|
0
|
$57.60 | -$89,731.00 | 924 |
Scheduled
|
Aug 29 - Aug 30
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 20
| |||
Form 4
|
—
|
0
|
$60.96 | -$103,192.00 | 924 |
Scheduled
|
Jul 10
| ||
Form 4
|
—
|
0
|
$64.03 | -$115,466.00 | 881 |
Scheduled
|
Jun 12
| ||
Form 4
|
—
|
0
|
$60.08 | -$99,682.80 | 881 |
Scheduled
|
May 11
| ||
Form 4
|
—
|
0
|
$58.27 | -$92,440.00 | 881 |
Scheduled
|
May 8
| ||
Form 4
|
—
|
0
|
$60.13 | -$99,870.00 | 881 |
Scheduled
|
Apr 12
| ||
Form 4
|
—
|
0
|
$58.75 | -$94,341.00 | 881 |
Scheduled
|
Mar 14
| ||
Form 4
|
—
|
0
|
$56.41 | -$84,985.00 | 881 |
Scheduled
|
Feb 16
| ||
Form 4
|
—
|
0
|
$56.96 | -$87,180.05 | 881 |
Scheduled
|
Feb 1
| ||
Form 4
|
—
|
0
|
$50.08 | -$179,040.00 | 881 |
Scheduled
|
Sep 11
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 16
| |||
Form 4
|
—
|
0
|
$77.91 | -$427,550.00 |
0
|
Scheduled
|
Jun 1
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
MIRAGEN THERAPEUTICS, INC. (VRDN) Snapshot price: $14.09
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Bicara Therapeutics Inc. (BCAX) No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||